Fine‐Mapping of <scp>HLA</scp> Effects in Oral and Non‐Oral Lichen Planus

ABSTRACT Lichen planus (LP) is an inflammatory disease affecting squamous epithelia, typically manifesting in a cutaneous (non‐OLP) and an oral mucosa (OLP) form, the latter conferring elevated risk of oral squamous cell carcinoma. Despite the presence of CD4+ and CD8+ T‐cell infiltrates in LP lesions, specific autoantibodies or target T‐cell antigens have not been identified. A recent genome‐wide association study (GWAS) uncovered 27 genome‐wide independent associations, with the strongest signal within HLA Class II, particularly involving DQB1*05:01 . This association showed stronger effects in non‐OLP (OR = 2.09) versus OLP (OR = 1.36). Here, we performed a high‐resolution HLA fine‐mapping analysis in FinnGen to dissect this strong Class II signal and clarify its relationship to LP subtypes. We find that most DQA1*01~DQB1*05:01 haplotypes confer increased susceptibility, with the highest risk conferred by DQA1*01:05~DQB1*05:01 followed by DQA1*01:01~DQB1*05:01 . In subjects not carrying DQB1*05:01 , DRB1*15:01~DQA1*01:02~DQB1*06:02 had a strong protective effect, more pronounced in non‐OLP than OLP. Further associations were found with DRB1*09:01 and DQB1*02:02 as well as independent HLA Class I associations with A*03:01 , B*08:01 and B*13:02 , all stronger in OLP versus non‐OLP. Conditioning SNP associations for these effects eliminated the HLA GWAS signal. These effects highlight that while the DQB1*05:01 association remains largely invariant to DQA1 polymorphisms across LP subtypes, the variable strength of HLA associations in non‐OLP and OLP forms suggests distinct immunopathological mechanisms. The presence of strong trans‐heterodimer effects in this disease illustrates the need to analyse HLA‐DQ ‐associated diseases with methods beyond simple conditioning. The invariance to DQA1 polymorphisms in LP may facilitate the identification of potential pathological epitopes.

Authors

Institutions

Publication Details

Journal
HLA
Published
2026-06-26
DOI
https://doi.org/10.1111/tan.70809
Primary Topic
Oral Health Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fine‐Mapping of HLA Effects in Oral and Non‐Oral Lichen Planus

Marcelo Fernández-Viña, Jukka Partanen, Mari Vehviläinen, Jarmo Ritari et al.
HLA
Oral Health Pathology and Treatment
article

Fine‐Mapping of HLA Effects in Oral and Non‐Oral Lichen Planus

Marcelo Fernández-Viña, Jukka Partanen, Mari Vehviläinen, Jarmo Ritari, Mary Pat Reeve, Kazutoyo Osoegawa, Benjamin Goudey, Emmanuel J. M. Mignot, Tuula Salo, Maria Siponen FinnGen
article en

Abstract

ABSTRACT Lichen planus (LP) is an inflammatory disease affecting squamous epithelia, typically manifesting in a cutaneous (non‐OLP) and an oral mucosa (OLP) form, the latter conferring elevated risk of oral squamous cell carcinoma. Despite the presence of CD4+ and CD8+ T‐cell infiltrates in LP lesions, specific autoantibodies or target T‐cell antigens have not been identified. A recent genome‐wide association study (GWAS) uncovered 27 genome‐wide independent associations, with the strongest signal within HLA Class II, particularly involving DQB1*05:01 . This association showed stronger effects in non‐OLP (OR = 2.09) versus OLP (OR = 1.36). Here, we performed a high‐resolution HLA fine‐mapping analysis in FinnGen to dissect this strong Class II signal and clarify its relationship to LP subtypes. We find that most DQA1*01~DQB1*05:01 haplotypes confer increased susceptibility, with the highest risk conferred by DQA1*01:05~DQB1*05:01 followed by DQA1*01:01~DQB1*05:01 . In subjects not carrying DQB1*05:01 , DRB1*15:01~DQA1*01:02~DQB1*06:02 had a strong protective effect, more pronounced in non‐OLP than OLP. Further associations were found with DRB1*09:01 and DQB1*02:02 as well as independent HLA Class I associations with A*03:01 , B*08:01 and B*13:02 , all stronger in OLP versus non‐OLP. Conditioning SNP associations for these effects eliminated the HLA GWAS signal. These effects highlight that while the DQB1*05:01 association remains largely invariant to DQA1 polymorphisms across LP subtypes, the variable strength of HLA associations in non‐OLP and OLP forms suggests distinct immunopathological mechanisms. The presence of strong trans‐heterodimer effects in this disease illustrates the need to analyse HLA‐DQ ‐associated diseases with methods beyond simple conditioning. The invariance to DQA1 polymorphisms in LP may facilitate the identification of potential pathological epitopes.

HLAVol. 108(1)
Broad Institute (US), University of Helsinki (FI), The University of Melbourne (AU), University of Eastern Finland (FI), Helsinki University Hospital (FI), Finnish Red Cross (FI), Kuopio University Hospital (FI), Stanford Blood Center (US), Institute for Molecular Medicine Finland (FI), Stanford Medicine (US), Hospital District of Helsinki and Uusimaa (FI), Oulu University of Applied Sciences (FI), University of Oulu (FI)
AstraZeneca UK, Boehringer Ingelheim, Pfizer, Biogen, Maze Therapeutics, Business Finland, Genentech, Janssen Biotech
Good health and well-being
Openalex Percentile: Top 7%
Oral Health Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.